Wellington Shields & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$708K Buy
8,175
+100
+1% +$9.58K 0.18% 111
2025
Q4
$776K Sell
8,075
-1,700
-17% -$165K 0.19% 104
2025
Q3
$931K Sell
9,775
-600
-6% -$55.2K 0.24% 91
2025
Q2
$904K Hold
10,375
0.26% 91
2025
Q1
$932K Sell
10,375
-3,600
-26% -$322K 0.29% 86
2024
Q4
$1.12M Hold
13,975
0.34% 68
2024
Q3
$1.26M Sell
13,975
-225
-2% -$18.9K 0.38% 62
2024
Q2
$1.12M Buy
14,200
+600
+4% +$49.2K 0.36% 62
2024
Q1
$1.19M Buy
13,600
+800
+6% +$68.3K 0.4% 58
2023
Q4
$1.05M Buy
12,800
+1,865
+17% +$142K 0.39% 60
2023
Q3
$857K Buy
10,935
+600
+6% +$50.2K 0.21% 70
2023
Q2
$911K Buy
10,335
+800
+8% +$68.9K 0.21% 68
2023
Q1
$769K Buy
+9,535
New +$777K 0.17% 78
2019
Q2
Sell
-2,891
Closed -$263K 177
2019
Q1
$263K Sell
2,891
-500
-15% -$44.8K 0.13% 137
2018
Q4
$308K Buy
+3,391
New +$317K 0.18% 119

Other funds holding MDT

Wellington Shields & Co's MDT Position: Q1 2026 in Review

Wellington Shields & Co increased its Medtronic (MDT) stake by 1.2% in Q1 2026, buying an estimated $9.58K and bringing the position to 8,175 shares worth $708K. The position accounts for 0.18% of the portfolio, ranked #111.

Wellington Shields & Co first reported a position in MDT in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.26M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Wellington Shields & Co held 8,175 shares of Medtronic worth $708K as of Q1 2026.
  • Wellington Shields & Co bought 100 Medtronic shares in Q1 2026, an estimated $9.58K.
  • Medtronic made up 0.18% of Wellington Shields & Co's portfolio in Q1 2026, its #111 holding.
  • Wellington Shields & Co first reported a position in Medtronic in Q4 2018 and has held it in 15 quarters since.
  • Wellington Shields & Co's Medtronic position peaked at $1.26M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.